Steminent Biotherapeutics Inc. (TPEX:7729)

Market Cap	6.00B
Revenue	n/a
Net Income	n/a
Shares Out	66.63M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	98,436
Average Volume	1,523,294
Open	88.40
Previous Close	90.00
Day's Range	88.20 - 90.80
52-Week Range	15.25 - 94.90
Beta	n/a
RSI	79.12
Earnings Date	n/a

About Steminent Biotherapeutics

Steminent Biotherapeutics Inc., operates as a biopharmaceutical company. Its product pipeline includes Stemchymal for treatment for polyglutamine spinocerebellar ataxia, huntington's disease, osteoarthritis, acute syndromes, such as respiratory distress syndrome, liver failure, ischemic stoke. The company was founded in 2009 and is based in Taipei, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7729